Cellular Senescence Agent
The Cellular Senescence Agent provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.
When to Use This Skill
- When identifying senescent cells in tissue or single-cell data.
- To analyze senescence-associated secretory phenotype (SASP).
- For predicting senolytic drug sensitivity.
- When studying therapy-induced senescence in cancer.
- To assess senescence burden in aging and disease.
Core Capabilities
Senescence Scoring: Calculate senescence signatures from transcriptomic data.
SASP Profiling: Characterize senescence-associated secretory phenotype composition.
Single-Cell Detection: Identify senescent cells in scRNA-seq data.
Senolytic Prediction: Predict sensitivity to senolytic drugs.
Tissue Aging: Assess senescence burden across tissues.
Cancer Senescence: Analyze therapy-induced senescence.
Senescence Markers
| Category |
Markers |
Detection |
| Cell cycle |
p16INK4a, p21CIP1, p53 |
Expression, IHC |
| SA-β-gal |
GLB1 (lysosomal) |
Activity assay |
| SASP |
IL-6, IL-8, MMP3, PAI-1 |
Expression, secretion |
| DNA damage |
γH2AX, 53BP1 foci |
Immunofluorescence |
| Morphology |
Enlarged, flattened |
Imaging |
| Epigenetic |
SAHF, SAHMs |
Chromatin marks |
Workflow
Input: Bulk or single-cell RNA-seq, proteomics, imaging data.
Signature Scoring: Apply senescence gene signatures.
SASP Analysis: Profile secretory phenotype.
Cell Identification: Flag senescent cells (single-cell).
Senolytic Prediction: Match to drug sensitivity profiles.
Burden Estimation: Quantify senescence load.
Output: Senescence scores, SASP profile, drug recommendations.
Example Usage
User: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."
Agent Action:
python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \
--rnaseq tissue_expression.tsv \
--singlecell tissue_scrnaseq.h5ad \
--signatures fridman_sasp,reactome_senescence \
--senolytic_prediction true \
--tissue liver \
--output senescence_report/
Senescence Gene Signatures
| Signature |
Genes |
Application |
| Fridman (2017) |
CDKN1A, CDKN2A, SERPINE1... |
Pan-senescence |
| SenMayo |
125 genes |
Tissue senescence |
| SASP Core |
IL6, IL8, CXCL1, MMP1... |
Secretory phenotype |
| p16/p21 pathway |
CDKN2A, CDKN1A, MDM2... |
Cell cycle arrest |
SASP Components
Pro-inflammatory:
- Interleukins: IL-1α/β, IL-6, IL-8
- Chemokines: CXCL1, CXCL2, CCL2
- Growth factors: TGF-β, VEGF
Matrix Remodeling:
- MMPs: MMP1, MMP3, MMP10
- Serpins: PAI-1 (SERPINE1)
Effects on Microenvironment:
- Paracrine senescence spread
- Immune cell recruitment
- ECM remodeling
- Tumor promotion (chronic) vs suppression (acute)
Senolytic Drugs
| Drug |
Target |
Clinical Status |
| Dasatinib |
Src/tyrosine kinases |
Trials (with Q) |
| Quercetin |
PI3K, serpins |
Trials (with D) |
| Navitoclax |
BCL-2/BCL-xL |
Trials |
| Fisetin |
Multiple |
Early trials |
| UBX1325 |
BCL-xL |
Phase 2 (macular) |
AI/ML Components
Senescence Classifier:
- Multi-gene signature scoring
- ML classifiers on expression
- Single-cell senescence probability
Drug Response:
- GDSC/CCLE senescence sensitivity
- SASP-drug correlations
- Synergy predictions
Aging Clock Integration:
- Epigenetic age correlation
- Transcriptomic age
- Senescence-aging relationships
Cancer Applications
Therapy-Induced Senescence (TIS):
- Chemotherapy, radiation
- CDK4/6 inhibitors (palbociclib)
- Dual outcomes: tumor suppression vs SASP-driven recurrence
Senescence + Senolytics:
- Induce senescence → clear with senolytics
- "One-two punch" approach
- Clinical trials ongoing
Prerequisites
- Python 3.10+
- Gene signature tools (GSVA, ssGSEA)
- Single-cell analysis (Scanpy)
- Drug response databases
Related Skills
- Single_Cell - For scRNA-seq analysis
- Cancer_Metabolism_Agent - For metabolic senescence
- Tumor_Microenvironment - For SASP effects
Research Applications
- Aging Research: Quantify senescence burden
- Cancer Therapy: Monitor TIS response
- Drug Development: Senolytic efficacy
- Fibrosis: Senescence in fibrotic disease
- Regeneration: Senescence in tissue repair
Author
AI Group - Biomedical AI Platform
1---2name: cellular-senescence-agent3description: AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.4---56<!--7# COPYRIGHT NOTICE8# This file is part of the "Universal Biomedical Skills" project.9# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>10# All Rights Reserved.11#12# This code is proprietary and confidential.13# Unauthorized copying of this file, via any medium is strictly prohibited.14#15# Provenance: Authenticated by MD BABU MIA1617-->18192021# Cellular Senescence Agent2223The **Cellular Senescence Agent** provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.2425## When to Use This Skill2627* When identifying senescent cells in tissue or single-cell data.28* To analyze senescence-associated secretory phenotype (SASP).29* For predicting senolytic drug sensitivity.30* When studying therapy-induced senescence in cancer.31* To assess senescence burden in aging and disease.3233## Core Capabilities34351. **Senescence Scoring**: Calculate senescence signatures from transcriptomic data.36372. **SASP Profiling**: Characterize senescence-associated secretory phenotype composition.38393. **Single-Cell Detection**: Identify senescent cells in scRNA-seq data.40414. **Senolytic Prediction**: Predict sensitivity to senolytic drugs.42435. **Tissue Aging**: Assess senescence burden across tissues.44456. **Cancer Senescence**: Analyze therapy-induced senescence.4647## Senescence Markers4849| Category | Markers | Detection |50|----------|---------|-----------|51| Cell cycle | p16INK4a, p21CIP1, p53 | Expression, IHC |52| SA-β-gal | GLB1 (lysosomal) | Activity assay |53| SASP | IL-6, IL-8, MMP3, PAI-1 | Expression, secretion |54| DNA damage | γH2AX, 53BP1 foci | Immunofluorescence |55| Morphology | Enlarged, flattened | Imaging |56| Epigenetic | SAHF, SAHMs | Chromatin marks |5758## Workflow59601. **Input**: Bulk or single-cell RNA-seq, proteomics, imaging data.61622. **Signature Scoring**: Apply senescence gene signatures.63643. **SASP Analysis**: Profile secretory phenotype.65664. **Cell Identification**: Flag senescent cells (single-cell).67685. **Senolytic Prediction**: Match to drug sensitivity profiles.69706. **Burden Estimation**: Quantify senescence load.71727. **Output**: Senescence scores, SASP profile, drug recommendations.7374## Example Usage7576**User**: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."7778**Agent Action**:79```bash80python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \81 --rnaseq tissue_expression.tsv \82 --singlecell tissue_scrnaseq.h5ad \83 --signatures fridman_sasp,reactome_senescence \84 --senolytic_prediction true \85 --tissue liver \86 --output senescence_report/87```8889## Senescence Gene Signatures9091| Signature | Genes | Application |92|-----------|-------|-------------|93| Fridman (2017) | CDKN1A, CDKN2A, SERPINE1... | Pan-senescence |94| SenMayo | 125 genes | Tissue senescence |95| SASP Core | IL6, IL8, CXCL1, MMP1... | Secretory phenotype |96| p16/p21 pathway | CDKN2A, CDKN1A, MDM2... | Cell cycle arrest |9798## SASP Components99100**Pro-inflammatory**:101- Interleukins: IL-1α/β, IL-6, IL-8102- Chemokines: CXCL1, CXCL2, CCL2103- Growth factors: TGF-β, VEGF104105**Matrix Remodeling**:106- MMPs: MMP1, MMP3, MMP10107- Serpins: PAI-1 (SERPINE1)108109**Effects on Microenvironment**:110- Paracrine senescence spread111- Immune cell recruitment112- ECM remodeling113- Tumor promotion (chronic) vs suppression (acute)114115## Senolytic Drugs116117| Drug | Target | Clinical Status |118|------|--------|-----------------|119| Dasatinib | Src/tyrosine kinases | Trials (with Q) |120| Quercetin | PI3K, serpins | Trials (with D) |121| Navitoclax | BCL-2/BCL-xL | Trials |122| Fisetin | Multiple | Early trials |123| UBX1325 | BCL-xL | Phase 2 (macular) |124125## AI/ML Components126127**Senescence Classifier**:128- Multi-gene signature scoring129- ML classifiers on expression130- Single-cell senescence probability131132**Drug Response**:133- GDSC/CCLE senescence sensitivity134- SASP-drug correlations135- Synergy predictions136137**Aging Clock Integration**:138- Epigenetic age correlation139- Transcriptomic age140- Senescence-aging relationships141142## Cancer Applications143144**Therapy-Induced Senescence (TIS)**:145- Chemotherapy, radiation146- CDK4/6 inhibitors (palbociclib)147- Dual outcomes: tumor suppression vs SASP-driven recurrence148149**Senescence + Senolytics**:150- Induce senescence → clear with senolytics151- "One-two punch" approach152- Clinical trials ongoing153154## Prerequisites155156* Python 3.10+157* Gene signature tools (GSVA, ssGSEA)158* Single-cell analysis (Scanpy)159* Drug response databases160161## Related Skills162163* Single_Cell - For scRNA-seq analysis164* Cancer_Metabolism_Agent - For metabolic senescence165* Tumor_Microenvironment - For SASP effects166167## Research Applications1681691. **Aging Research**: Quantify senescence burden1702. **Cancer Therapy**: Monitor TIS response1713. **Drug Development**: Senolytic efficacy1724. **Fibrosis**: Senescence in fibrotic disease1735. **Regeneration**: Senescence in tissue repair174175## Author176177AI Group - Biomedical AI Platform178179180<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->